We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Pfizer is the latest pharma giant to join Cambridge-based Milner Therapeutics Consortium, a global therapeutic alliance that aims to enable the transfer of materials between industry and academia.